| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Tang,Zhi-Chao | Chairman | 15.64% | ANDREW INVESTMENT LIMITED |
| Liu,Dai-Lin | Director | 12.41% | HANZTECH ELEVATOR CORPORATION |
| Liu,Chao-An | Director | 7.09% | XU AN INVESTMENT CO., LTD. |
| Lian,Jia-He | Independent Director | 0.00% | |
| Fu,Ji-Qing | Independent Director | 0.00% | |
| Wang,Zhong-Ping | Independent Director | 0.00% | |
| Shi,Nan-Guang | Independent Director | 0.00% |
Change Company Name to LUKAS BIOMEDICAL INC.
2024/07/09
Change Company Name to LUKE BIOMEDICAL CO., LTD. (FORMER NAME: CARMEL INDUSTRIAL CO., LTD.)
2022/10/14
Change Capital to 500,000,000
2018/01/30
Change Person in Charge to Tang,Zhi-Chao
2017/08/08
Change Capital to 200,000,000
2017/06/12
Change Capital to 29,500,000
2015/11/17
Change Person in Charge to Fan,Xin-Lu
2015/11/17
Change Company Name to LUKAS BIOMEDICAL INC.
2014/08/22
Change Capital to 15,500,000
2014/08/22
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 97,424 | 231,833 | 184,787 |
| Operating cost | 39,082 | 97,943 | 86,881 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 58,342 | 133,890 | 97,906 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 58,342 | 133,890 | 97,906 |
| Operating expenses | 97,252 | 177,450 | 146,372 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -38,910 | -43,560 | -48,466 |
| Non-operating income and expenses | -1,755 | -3,715 | -1,453 |
| Net profit (loss) before tax | -40,665 | -47,275 | -49,919 |
| Income tax expense (benefits) | 0 | 78 | 151 |
| Net profit (loss) of ongoing business for the current period | -40,665 | -47,353 | -50,070 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -40,665 | -47,353 | -50,070 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -40,665 | -47,353 | -50,070 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | -1 | -1 | -1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | - | - | - |
| Net cash inflows (outflows) from investing activities | - | - | - |
| Net cash inflow (outflow) from financing activities | - | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
| Beginning balance of cash and cash equivalents | - | - | - |
| Ending balance of cash and cash equivalents | - | - | - |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 235,985 | 87,370 | 105,528 |
| Non-current asset | 343,538 | 353,821 | 374,138 |
| Total asset | 579,523 | 441,191 | 479,666 |
| Current liability | 107,978 | 57,654 | 56,445 |
| Non-current liability | 92,011 | 103,405 | 95,736 |
| Total liability | 199,989 | 161,059 | 152,181 |
| share capital | 418,744 | 368,744 | 368,744 |
| Equity - secruity token | - | - | - |
| capital reserve | 90,067 | 0 | 96,174 |
| retained earning | -129,277 | -88,612 | -137,433 |
| Other equity | - | 0 | 0 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 379,534 | 280,132 | 327,485 |
| Share capital awaiting retirement (unit: share) | 0 | - | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 9 | 7 | 8 |
